Can two drugs help mice lose weight and quit nicotine?
GLP-1 and nicotine combination therapy engages hypothalamic and mesolimbic pathways to reverse obesity
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists gave mice two drugs: one that mimics nicotine and one that helps control appetite. Together, the mice ate less, burned more energy, and avoided nicotine.
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Systematic Reviews & Meta-Analyses
Max 100Randomized Controlled Trials
Max 90Cohort Studies
Max 72Case-Control Studies
Max 58Cross-Sectional Studies
Max 44Case Reports & Case Series
Max 30Expert Opinion & Narrative Reviews
Max 56 / 72
Evidence Score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists gave mice two drugs: one that mimics nicotine and one that helps control appetite. Together, the mice ate less, burned more energy, and avoided nicotine.
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Systematic Reviews & Meta-Analyses
Max 100Randomized Controlled Trials
Max 90Cohort Studies
Max 72Case-Control Studies
Max 58Cross-Sectional Studies
Max 44Case Reports & Case Series
Max 30Expert Opinion & Narrative Reviews
Max 56 / 72
Evidence Score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Publication
Authors
Falk S, Petersen J, Svendsen C, Romero-Leguizamón CR, Jørgensen SH, Krauth N, Ludwig MQ, Lundø K, Roostalu U, Skovbjerg G, Nielsen DAG, Ejdrup AL, Pers TH, Dmytriyeva O, Hecksher-Sørensen J, Gether U, Kohlmeier KA, Clemmensen C
Related Content
Claims (6)
Nicotine acts as an appetite suppressant via central nervous system activation of hypothalamic satiety pathways independent of tobacco-derived toxins.
Giving mice both nicotine and a diabetes drug called liraglutide together helps them lose weight by making them eat less and burn more calories.
A drug that activates GLP-1 receptors makes certain brain cells in mice more active — specifically ones that control appetite and reward.
When mice get both nicotine and liraglutide, several parts of their brain light up with activity, suggesting the two drugs work together in the brain.
Mice given GLP-1 drugs tend to avoid nicotine, suggesting these drugs might reduce the appeal of nicotine.